Lee, Ikjae; Kuo, Hui-Chien; Aban, Inmaculada B.; Cutter, Gary R.; McPherson, Tarrant; Kaminski, Henry J.; Sussman, Jon; Strobel, Philipp; Oger, Joel; Cea Muñoz, Gabriel; Heckmann, Jeannine M.; Evoli, Amelia; Nix, Wilfred; Ciafaloni, Emma; Antonini, Giovanni; Witoonpanich, Rawiphan; King, John O.; Beydoun, Said R.; Chalk, Colin H.; Barboi, Alexandru C.; Amato, Anthony A.; Shaibani, Aziz I.; Katirji, Bashar; Lecky, Bryan R. F.; Buckley, Camilla; Vincent, Angela; Dias-Tosta, Elza; Yoshikawa, Hiroaki; Waddington-Cruz, Marcia; Pulley, Michael T.; Rivner, Michael H.; Kostera-Pruszczyk, Anna; Pascuzzi, Robert M.; Jackson, Carlayne E.; Verschuuren, Jan J. G.; Massey, Janice M.; Kissel, John T.; Werneck, Lineu C.; Benatar, Michael; Barohn, Richard J.; Tandan, Rup; Mozaffar, Tahseen; Conwit, Robin; Minisman, Greg; Sonett, Joshua R.; Wolfe, Gil I. (Lippincott Williams & Wilkins, 2020)
To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG).
Methods
This study is a post hoc analysis ...
